Smith & Nephew reported annual revenues exceeding $5 billion this week, sparking a 7% rise in its stock in the first quarter under the leadership of Roland Diggelmann.
The ex-CEO of Roche Diagnostics presented the results on Thursday, the same day as NuVasive, a rumored takeover target for Smith & Nephew about a year ago, and...
